Despite an increase in diagnosis times, South Africa is facing a growing drug-resistant tuberculosis (TB) burden as nationally there remains a large gap between the number of patients diagnosed with multidrug-resistant TB (MDR-TB) and those who start treatment.
8 hours ago | Inter Press Service
While it is disappointing that the Xpert did not confer a morbidity or mortality benefit, its advantages include quicker and easier diagnosis with less work for health workers.
10 March 2014 | HIV i-Base
Gavin Churchyard and Katherine Fielding presented results this morning from the XPert for TB: Evaluating a New Diagnostic Trial (EXTEND) on the question of whether Xpert MTB/RIF diagnostic test reduces early mortality in adults with suspected TB, facilitates earlier initiation of TB treatment and antiretroviral therapy and reduces the number of patients
05 March 2014 | Science Speaks
Letter to Cepheid cites continued cost of machines, Russia, China cartridge costs of five to six times negotiated price, and more.
28 January 2014 | Science Speaks
News-Medical.net reported on a second systematic review of the Xpert® MTB/RIF TB test, which is endorsed by the World Health Organization (WHO). WHO commissioned this updated Cochrane Review as part of the process to update the policy on the use of the test.
23 January 2014 | CDC National Prevention Information Network
In the second of two linked posts, Lindsay McKenna and Colleen Daniels of Treatment Action Group (TAG) describe the importance of access to timely diagnosis and appropriate treatment for patients with drug-resistant tuberculosis and demand that urgency be returned to the global DR-TB response.
04 November 2013 | PLoS Blogs
A new, sophisticated diagnostic test for tuberculosis now being rolled out promises to be faster and more accurate than the old methods and much easier to use. But the first trials of the GeneXpert MTB/RIF Assay test in real-life situations have proved that while all this is true, it did not make any significant difference to treatment outcomes.
30 October 2013 | IRIN
Tuberculosis (TB) treatment has saved the lives of more than 22 million people, according to the WHO "Global tuberculosis report 2013" published today. The report also reveals that the number of people ill with TB fell in 2012 to 8.6 million, with global TB deaths also decreasing to 1.3 million.
23 October 2013 | World Health Organization (press release)
London may be famed for its historic sites, double-decker buses and West End shows, but it now has a more dubious distinction: It has become the tuberculosis capital of Western Europe.In response, health officials are taking to the streets in an effort to stop the spread of the infectious lung disease, with a high-tech white van equipped with an X-ray machine that drives around London offering free check-ups.
23 October 2013 | Washington Post
Public health officials are planning a nationally co-ordinated programme of targeted TB screening in primary care, to combat rising infection rates in some urban areas of England. Experts at Public Health England (PHE) claim the best way to ‘reverse the tide’ is for GP practices to start screening for latent TB in at-risk groups, particularly immigrants from areas with a high incidence of the disease.
18 October 2013 | Pulse